Pharma Connect Congress

India, considered as pharmacy of the world, is the largest provider of generic drugs globally. It ranks 3rd in terms of pharmaceutical production by volume and 14th by value. India's pharma and biopharma sector is experiencing explosive growth, projected to reach a staggering $130 billion by 2030. This surge is fueled by a large, demanding domestic market, a robust manufacturing base churning out generics, and India's position as a global vaccine powerhouse, supplying over 60% of the world's needs.

The Pharma Manufacturing India Conclave 2025 is curated to address critical discussions on the theme India as Global Leader in the pharma space with focus on manufacturing. Decision-makers from manufacturers, academics, industry associations, contract manufacturing organisations and other key stakeholders gather under one roof to brainstorm on navigating the challenges and discuss the road ahead. The program will discuss smart manufacturing for all, innovation required in pharma R&D, how to go up in the innovation curve, attracting the required skill set, and much more